| • |
Company records 46% sales growth over year 2003
|
| • |
Global presence in 59 countries
|
| • |
Sterile injectable parenteral manufacturing facility receives several international regulatory appprovals including MHRA(UK) and MOH Indonesia.
|
| • |
247 product registrations world wide
|
| • |
Inauguration of infusion project and enteral nutrition manufacturing facility
|
| • |
First international approval for infusion plant from MOH, Yemen
|
| • |
WHO GMP for Injectable and Infusion manufacturing facilities |
| • |
Injectable plant receives IDMA Quality Excellence Award 2004 |
| • |
Injectable plant receives ISO 9001:2000 certification |
|
| • |
Foundation stone of API plant laid |
| • |
Inauguration of laboratory in Mexico |
| • |
Inauguration of office in Bogota, Colombia |
| • |
First order received from the U.S.A. |
| • |
New products Sufentil (Sufentanil Citrate Injection), TNA/TNA Peri (Triple Chamber Nutrition System), Limus (Sirolimus) tablets, Norglobin (Immunoglobulin) IVIG |
| • |
Patent for an improved process of producing pyrogen free Hydroxyethyl starch approved by the Patents Office, Govt. of India |
| • |
Claris Critical Care Oration Award 2004 given to Dr. R. Ramakantan, Professor & Head, Dept. of Radiology, KEM, Mumbai |
| • |
2nd Claris International Critical Care International Achievement Award given to Dr. Balavenkatesh, Brisbane, Australia |
|
